Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Insulin Resistance and Statin Treatment in Renal Transplant Recipients and CKD
2022-501068-16-00Phase 2Completed
- Sponsor
- Aarhus University Hospital
- Start
- Sep 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial in insulin resistance (IR), chronic kidney disease (CKD) and Kidney allograft status (RTx) comparing Pravastatin with Placebo (2 arms). Primary endpoint: Insulin sensitivity. Started Sep 2022; status: completed.
02
Drugs
pravastatin
03
Conditions
insulin resistance (IR)chronic kidney disease (CKD)Kidney allograft status (RTx)
Beyond the preview
Go deeper on 2022-501068-16-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2022-501068-16-00.